Notably, however, in contrast to patients with rheumatoid arthritis, Lp(a) was not modified by IL-6R inhibition by tocilizumab in patients with non-ST-elevation MI (NSTEMI) [94]. The gene discussed is IL6R; the disease is rheumatoid arthritis.